Exploring Long-term Pain Relief with 5% Dextrose Added to Local Anesthetic

NAActive, not recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 3, 2024

Primary Completion Date

January 30, 2025

Study Completion Date

February 28, 2025

Conditions
Chronic Non-cancer Pain
Interventions
DRUG

Addition of 1 mL of 50% dextrose solution to the usual local anesthetic solution of choice for each patient.

"The principal investigator will use a palpation-guided approach to select the injection sites. Injection solutions will be prepared by the assisting nurse. For each patient, 1 mL of a 50% dextrose solution (Pfizer Canada ULS, Kirkland, Québec) will be added to the usual local anesthetic solution of choice.~Solutions contain either 0.3% Ropivacaine, 1% Procaine, 0.5% Lidocaine, 0.25% Bupivacaine, or a mixture of 0.25% Bupivacaine and 2% Lidocaine in a 9:1 ratio."

Trial Locations (1)

K1Z 5Z9

Seekers Centre, Ottawa

All Listed Sponsors
lead

The Seekers Centre

OTHER

NCT06617065 - Exploring Long-term Pain Relief with 5% Dextrose Added to Local Anesthetic | Biotech Hunter | Biotech Hunter